Good morning to you all. Please find enclosed a summary of the breaking small-cap and micro-cap financial news we highlighted on AGORACOM Small Cap TV this morning. It’s November 18th, 2011, and we’ve found 1 great press release to report on at the open. Another great day for small-cap and micro-cap financial news. To watch the show live every morning at 9:30 AM, visit our front page.

China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED - News), a leading China -based advanced in-vitro diagnostic ("IVD") company, announced its unaudited financial results for the second fiscal quarter ended September 30, 2011 ("2Q FY2011") today.

Highlights

The Company reported net revenues of US$37.4 million for 2Q FY2011, representing an 18.1% increase from the corresponding period of FY2010.

Gross margin was 64.9% for 2Q FY2011 which increased year-over-year from 55.2% for the corresponding period of FY2010.

Net income was US$5.2 million for 2Q FY2011, compared to net loss of US$ 0.46 million for the corresponding period of FY2010. Non-GAAP net income was US$14.0 million )for 2Q FY2011, representing a 36.9% increase from the corresponding period of FY2010.

About China Medical Technologies, Inc.

China Medical Technologies, Inc. is a leading China -based advanced IVD company using molecular diagnostic technologies including Fluorescent in situ Hybridization (FISH) and Surface Plasmon Resonance (SPR) and an immunodiagnostic technology, Enhanced Chemiluminescence Immunoassay (ECLIA), to develop, manufacture and distribute diagnostic products used for the detection of various cancers, diseases and disorders as well as companion diagnostic tests for targeted cancer drugs.

Last Trade: 3.8552 Week: 14.00 – 3.65Market Cap: 124.23 Million